Keystone Symposia

Paul J. Converse PhD

Johns Hopkins University

Appearances

Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis
Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis
The next-generation diarylquinoline TBAJ-587 has superior efficacy against, and restricts selection of, bedaquiline-resistant Rv0678 mutants in a mouse model of tuberculosis

Item	Price	Remove